Glaucoma News

Glaucoma is a major blinding disease. The onset is hidden, and early diagnosis is difficult. Cost-effective screening tools are lacking, and often we diagnose the disease when the optic nerve damage is irreversible.

The global population in 2024 is just more than 8 billion. One-half of the world’s population, or at least 4 billion people, reside in emerging countries with less well-developed economies and health care systems.

Minimally invasive glaucoma surgery could potentially offer an effective alternative to lifelong use of medications at a global level.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Norbert Koerber, MD, PhD, summarizes the 6-year data of ab interno canaloplasty with the iTrack microcatheter from Nova Eye Medical.

Overdiagnosis and overtreatment are growing problems in glaucoma, and ophthalmologists must work toward finding solutions, according to a lecturer at the American Glaucoma Society meeting.

WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Renee Bovelle, MD, discusses the benefits of using Iyuzeh to treat glaucoma while not inducing dry eye.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Aylin Kiliç, MD, predicts that customized additive strategies will be the future of refractive surgery.

The travoprost intraocular implant demonstrated a reduction in IOP in patients with open-angle glaucoma or ocular hypertension 3 months after a single administration, according to a study published in Ophthalmology.

Modern glaucoma care is all about the patient, according to a speaker at the American Glaucoma Society meeting.

TAMPA, Fla. — In this Healio Video Perspective from Telling It Like It Is, Steven R. Sarkisian Jr., MD, explains why endoscopic cyclophotocoagulation, or ECP, is still a “powerful tool” for glaucoma treatment.